Physician profile
Keith Feder
NPI 1821134123
$1,789.16
in general payments reported to CMS, 2019-2025
21 companies · $229 in 2025
The $229 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $412 · 2020: $109 · 2021: $244 · 2022: $78.83 · 2023: $406 · 2024: $310 · 2025: $229.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $945.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $945.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Saxum Surgical, INC. | $289.29 | 2023 | |
| Stryker Corporation | $258.16 | 2019-2021 | |
| Fidia Pharma USA INC. | $243.58 | 2020-2025 | Triluron, Hymovis, Hyalgan |
| Miach Orthopaedics, INC. | $183.35 | 2024 | |
| Bioventus LLC | $137.81 | 2022-2025 | Gelsyn-3, Exogen Ultrasound Bone Healing System, Xcell |
| Vericel Corporation | $115.25 | 2019-2025 | Maci |
| Pfizer INC. | $70.45 | 2019-2021 | |
| Depuy Synthes Sales INC. | $68.70 | 2019-2023 | Orthovisc |
| Pacira Therapeutics, INC. | $64.50 | 2019-2021 | |
| Horizon Therapeutics Plc | $58.79 | 2019-2022 | |
| Zimmer Biomet Holdings, INC. | $58.39 | 2019-2023 | Gel-One Cross-Linked Hyaluronate |
| Boston Scientific Corporation | $42.75 | 2023 | Wavewriter Alpha Prime 16 |
| Vertex Pharmaceuticals Incorporated | $33.84 | 2024 | |
| Linvatec Corporation | $26.89 | 2025 | Biobrace 23mm |
| Orthofix Medical, INC. | $26.17 | 2025 | Physio-Stim |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ibsa Pharma INC. | $24.61 | 2024 | Tirosint, Licart |
| Curonix LLC | $21.44 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Avanos Medical | $18.37 | 2024 | Trivisc Sodium Hyaluronate |
| Team_makena_llc | $16.00 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $15.75 | 2023 | Zilretta |
| Ferring Pharmaceuticals INC. | $15.07 | 2025 | Euflexxa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Keith Feder listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.